Treatment Options for Insomnia
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for all adults with chronic insomnia disorder due to its proven effectiveness and lack of side effects. 1
First-Line Treatment: Psychological and Behavioral Interventions
Cognitive Behavioral Therapy for Insomnia (CBT-I)
- CBT-I is strongly recommended as the initial treatment for chronic insomnia based on moderate-quality evidence 1
- CBT-I is effective for both primary and comorbid (secondary) insomnia 1
- CBT-I typically includes multiple components: cognitive therapy, stimulus control, sleep restriction, with or without relaxation therapy 1
- CBT-I is effective for adults of all ages, including older adults and chronic hypnotic users 1, 2
- CBT-I produces results equivalent to sleep medication but with no side effects, fewer relapses, and continued improvement after treatment ends 3
Other Effective Behavioral Interventions
- Stimulus control therapy (establishing a positive association between bed and sleep) is an effective individual therapy 1, 2
- Relaxation therapy is effective as a standalone treatment for chronic insomnia 1, 2
- Sleep restriction therapy is recommended for chronic insomnia 1
- Brief Behavioral Interventions (BBIs) are potentially useful with minimal undesirable effects 1
- Multicomponent therapy (without cognitive therapy) is effective and recommended 1
Sleep Hygiene Considerations
- Sleep hygiene alone is insufficient for treating chronic insomnia 1, 4
- Sleep hygiene should be used in combination with other therapies, not as a standalone treatment 1, 4
- All patients with chronic insomnia should adhere to rules of good sleep hygiene as part of a comprehensive treatment plan 1
Second-Line Treatment: Pharmacological Options
When CBT-I alone is unsuccessful, pharmacological therapy may be considered using a shared decision-making approach that discusses benefits, harms, and costs of short-term medication use 1.
Recommended Medication Sequence
Short-intermediate acting benzodiazepine receptor agonists or ramelteon 1
If initial agent unsuccessful, try alternate short-intermediate acting BzRAs or ramelteon 1
Sedating antidepressants (especially with comorbid depression/anxiety) 1
- Options include trazodone, amitriptyline, doxepin, and mirtazapine 1
Combined BzRA or ramelteon with sedating antidepressant 1
Other sedating agents 1
Important Medication Considerations
- Short-term hypnotic treatment should be supplemented with behavioral and cognitive therapies when possible 1
- Over-the-counter antihistamines and herbal/nutritional substances (valerian, melatonin) are not recommended due to lack of efficacy and safety data 1
- Barbiturates, barbiturate-type drugs, and chloral hydrate are not recommended 1
- Zolpidem is FDA-approved for short-term treatment of insomnia characterized by difficulties with sleep initiation 5
- Newer-generation nonbenzodiazepines have better safety profiles than traditional benzodiazepines for long-term treatment 7
Treatment Selection Factors
When selecting pharmacological treatment, consider: 1
- Symptom pattern (sleep onset vs. maintenance issues)
- Treatment goals
- Past treatment responses
- Patient preference
- Cost
- Availability of other treatments
- Comorbid conditions
- Contraindications
- Medication interactions
- Side effects
Monitoring and Follow-up
- Sleep diary data should be collected before and during treatment, and in case of relapse 1
- Clinical reassessment should occur every few weeks until insomnia stabilizes or resolves 1
- After stabilization, follow-up every 6 months is recommended as relapse rates for insomnia are high 1
- When a single treatment is ineffective, consider other behavioral therapies, pharmacological options, combined therapies, or reevaluation for comorbid disorders 1
Common Pitfalls to Avoid
- Relying solely on sleep hygiene education without additional interventions 1
- Using over-the-counter antihistamines or alcohol as sleep aids 1, 7
- Prescribing medications without addressing behavioral components 1
- Failing to reassess treatment effectiveness regularly 1
- Not considering potential for dependence with long-term benzodiazepine use 7
- Overlooking comorbid conditions that may be contributing to insomnia 1